Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of AD-221 and AD-221A for primary hypercholesterolemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• AD-221 (AD-221)
• AD-221A (AD-221A)

Snippet

Sponsor: Addpharma Inc. | Conditions: Primary Hypercholesterolemia | Phase 3 | Status: COMPLETED